Skip to main content

PORTLAND INVESTMENT COUNSEL INC.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1081668 BURLINGTON, A6

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$407,795
-$97,511 QoQ
Shares Held
654
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#858
of 1,322 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PORTLAND INVESTMENT COUNSEL INC. holds $5,865,331 across 9 Biotechnology names. REGN ranks #5 (7.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 REGN
Regeneron Pharmaceuticals, Inc.
This page
654 $407,795

All Filings in REGN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $407,795 654
2026-03-31 $505,306 654
2024-09-30 $340,601 324
2024-06-30 $340,533 324
2024-03-31 $314,734 327
2023-12-31 $287,200 327
2023-09-30 $269,107 327
2023-06-30 $237,118 330
2023-03-31 $271,151 330
2022-12-31 $238,091 330
2022-09-30 $227,327 330
2022-03-31 $230,478 330
2021-12-31 $207,770 329